Federal Capture Intelligence

Top HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) contractors (NAICS 541715)

Contract actions: October 1, 2021 – October 13, 2026 Updated October 14, 2026 Department of Health and Human Services agency guide NAICS 541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Latest 12 months
$1.4B
Net obligations · Down $13.2M vs. $1.4B preceding
Prime contractors
228
With positive obligations in the latest 12 months

Research the HHS federal contracting market for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) under NAICS 541715. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, observed contract vehicle usage, and potential recompete research leads.

Contract obligation trends for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services

Federal records show $10.2B in net obligations across 2,719 awards in Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services from Oct 1, 2021 through Oct 13, 2026. This market accounts for 6.8% of $150.1B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 0.9% from $1.4B to $1.4B. 39 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY27 is year-to-date through Oct 13, 2026; earlier years show complete fiscal-year totals.

FY27 year-to-date: −$24K versus $0 through the same date in FY26 (Not comparable).
Net obligations · complete fiscal yearNet obligations · FY27 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$2.1B1,871Complete
FY2023$3.1B1,814Complete
FY2024$2.2B2,036Complete
FY2025$1.4B1,765Complete
FY2026$1.4B1,455Complete

Market at a glance

All reported prime contract awards
All-period net obligations
$10.2B
2,719 awards · 827 prime contractors
Latest 12-month movement
−0.9%
$1.4B vs. $1.4B
Leading eight prime share
57.9%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
6.8% of $150.1B in agency-wide net obligations.
Set-aside share when reported
28.5% of 1,395 awards with reported set-aside status.
Set-aside reporting
398 set aside · 997 no set-aside · 1,324 not reported

What changed in the last 12 months?

Oct 14, 2025–Oct 13, 2026, compared with Oct 14, 2024–Oct 13, 2025.

Competitive shifts

LEIDOS BIOMEDICAL RESEARCH INC lost the most market share
39.2%→29.9%−9.3 percentage points
The contractor now ranks #1 by positive obligations, based on 154 reported actions.
REVAGENIX INC climbed the most in the contractor rankings
#133→#15Up 118 places
The contractor accounts for 0.98% of positive obligations across 8 reported actions.

Buyer demand

Reported obligations through NIH NCI decreased
$644.5M→$383.6M−$260.9M
Latest-period activity spans 148 awards across 60 prime contractors.
Reported obligations through NATIONAL INSTITUTES OF HEALTH NCATS increased
$61K→$113.1M+$113.1M
Latest-period activity spans 23 awards across 8 prime contractors.

Award activity

View 3 additional material changes

Competitive shifts

THE MITRE CORPORATION had the largest increase in reported obligations
$123.7M→$163.3M+$39.6M
The contractor now ranks #2 by positive obligations and accounts for 11.3% of positive obligations, based on 82 reported actions.
14 contractors were first observed in this market during the latest 12 months
$29.0MLatest 12-month obligations
Contractor-level obligations and first-observed dates appear below. “First observed” applies only to this market and the period shown.
View 14 contractors
ContractorLatest 12 months
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Oct 13, 2026.

26.7% of positive obligations were attributed to NIH NCI. That represents $383.6M, down $260.9M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. NIH NCI26.7% · $383.6M · down $260.9M
  2. NATIONAL INSTITUTES OF HEALTH NIAID21.6% · $309.4M · down $11.8M
  3. OFC OF ACQUISITION AND GRANTS MGMT8.6% · $123.2M · up $29.9M
  4. NATIONAL INSTITUTES OF HEALTH NCATS7.9% · $113.1M · up $113.1M
  5. NATIONAL INSTITUTES OF HEALTH NHLBI7.0% · $100.4M · up $6.6M
  6. All other reported offices28.2% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    NIH NCI

    #1Rank unchanged

    Latest 12 months

    $383.6M

    26.7% of positive obligations

    Versus preceding 12 months

    −$260.9M

    60 active prime contractors · 148 awards

    View office comparison and evidence

    Reported obligations decreased 40.5% from $644.5M to $383.6M. The office’s share of positive obligations moved from 44.5% to 26.7%, a change of −17.8 percentage points.

    The latest period contains 225 actions across 148 awards and 10 newly active prime contractors. The preceding period contained 82 active prime contractors and 192 awards.

    Leading award-level changes

  2. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIAID

    #2Rank unchanged

    Latest 12 months

    $309.4M

    21.6% of positive obligations

    Versus preceding 12 months

    −$11.8M

    81 active prime contractors · 165 awards

    View office comparison and evidence

    Reported obligations decreased 3.7% from $321.1M to $309.4M. The office’s share of positive obligations moved from 22.2% to 21.6%, a change of −0.6 percentage points.

    The latest period contains 314 actions across 165 awards and 13 newly active prime contractors. The preceding period contained 108 active prime contractors and 203 awards.

  3. Reported funding office

    OFC OF ACQUISITION AND GRANTS MGMT

    #3Up 1 from #4

    Latest 12 months

    $123.2M

    8.6% of positive obligations

    Versus preceding 12 months

    +$29.9M

    1 active prime contractor · 20 awards

    View office comparison and evidence

    Reported obligations increased 32.0% from $93.3M to $123.2M. The office’s share of positive obligations moved from 6.5% to 8.6%, a change of +2.1 percentage points.

    The latest period contains 39 actions across 20 awards. The preceding period contained 2 active prime contractors and 23 awards.

  4. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NCATS

    #4Up 27 from #31

    Latest 12 months

    $113.1M

    7.9% of positive obligations

    Versus preceding 12 months

    +$113.1M

    8 active prime contractors · 23 awards

    View office comparison and evidence

    Reported obligations increased 184718.1% from $61K to $113.1M. The office’s share of positive obligations moved from 0% to 7.9%, a change of +7.9 percentage points.

    The latest period contains 23 actions across 23 awards and 5 newly active prime contractors. The preceding period contained 5 active prime contractors and 10 awards.

    Leading award-level changes

  5. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NHLBI

    #5Down 2 from #3

    Latest 12 months

    $100.4M

    7.0% of positive obligations

    Versus preceding 12 months

    +$6.6M

    47 active prime contractors · 126 awards

    View office comparison and evidence

    Reported obligations increased 7.0% from $93.9M to $100.4M. The office’s share of positive obligations moved from 6.5% to 7.0%, a change of +0.5 percentage points.

    The latest period contains 163 actions across 126 awards and 3 newly active prime contractors. The preceding period contained 53 active prime contractors and 169 awards.

  6. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIDA

    #6Down 1 from #5

    Latest 12 months

    $75.2M

    5.3% of positive obligations

    Versus preceding 12 months

    +$5.7M

    35 active prime contractors · 86 awards

    View office comparison and evidence

    Reported obligations increased 8.2% from $69.5M to $75.2M. The office’s share of positive obligations moved from 4.8% to 5.3%, a change of +0.5 percentage points.

    The latest period contains 116 actions across 86 awards and 11 newly active prime contractors. The preceding period contained 31 active prime contractors and 92 awards.

  7. Reported funding office

    BARDA - ASPR / DAAPPO / BARDA DCMA

    #7Up 3 from #10

    Latest 12 months

    $70.6M

    4.9% of positive obligations

    Versus preceding 12 months

    +$51.2M

    20 active prime contractors · 31 awards

    View office comparison and evidence

    Reported obligations increased 263.4% from $19.4M to $70.6M. The office’s share of positive obligations moved from 1.3% to 4.9%, a change of +3.6 percentage points.

    The latest period contains 61 actions across 31 awards and 7 newly active prime contractors. The preceding period contained 26 active prime contractors and 36 awards.

  8. Reported funding office

    NATIONAL INSTITUTE OF HEALTH NIEHS

    #8Down 2 from #6

    Latest 12 months

    $50.1M

    3.5% of positive obligations

    Versus preceding 12 months

    +$13.4M

    7 active prime contractors · 8 awards

    View office comparison and evidence

    Reported obligations increased 36.6% from $36.7M to $50.1M. The office’s share of positive obligations moved from 2.5% to 3.5%, a change of +1.0 percentage points.

    The latest period contains 21 actions across 8 awards and 2 newly active prime contractors. The preceding period contained 6 active prime contractors and 7 awards.

  9. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NICHD

    #9Down 1 from #8

    Latest 12 months

    $42.8M

    3.0% of positive obligations

    Versus preceding 12 months

    +$16.1M

    18 active prime contractors · 61 awards

    View office comparison and evidence

    Reported obligations increased 60.0% from $26.8M to $42.8M. The office’s share of positive obligations moved from 1.9% to 3.0%, a change of +1.1 percentage points.

    The latest period contains 87 actions across 61 awards and 8 newly active prime contractors. The preceding period contained 17 active prime contractors and 73 awards.

  10. Reported funding office

    FDA OFFICE OF ACQ GRANT SVCS

    #10Up 1 from #11

    Latest 12 months

    $34.7M

    2.4% of positive obligations

    Versus preceding 12 months

    +$22.4M

    46 active prime contractors · 63 awards

    View office comparison and evidence

    Reported obligations increased 183.2% from $12.2M to $34.7M. The office’s share of positive obligations moved from 0.85% to 2.4%, a change of +1.6 percentage points.

    The latest period contains 71 actions across 63 awards and 31 newly active prime contractors. The preceding period contained 31 active prime contractors and 41 awards.

  11. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIA

    #22Down 9 from #13

    Latest 12 months

    $2.0M

    0.14% of positive obligations

    Versus preceding 12 months

    −$7.7M

    7 active prime contractors · 7 awards

    View office comparison and evidence

    Reported obligations decreased 79.5% from $9.7M to $2.0M. The office’s share of positive obligations moved from 0.67% to 0.14%, a change of −0.5 percentage points.

    The latest period contains 7 actions across 7 awards and 4 newly active prime contractors. The preceding period contained 9 active prime contractors and 11 awards.

  12. Reported funding office

    AHRQ/HEALTHCARE RESEARCH QUALITY

    #24Down 10 from #14

    Latest 12 months

    $1.3M

    0.090% of positive obligations

    Versus preceding 12 months

    −$6.6M

    10 active prime contractors · 21 awards

    View office comparison and evidence

    Reported obligations decreased 83.2% from $8.0M to $1.3M. The office’s share of positive obligations moved from 0.55% to 0.090%, a change of −0.5 percentage points.

    The latest period contains 30 actions across 21 awards. The preceding period contained 13 active prime contractors and 63 awards.

  13. Reported funding office

    OFFICE OF ACQ GRANTS MGMT

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$6.5M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $6.5M to $0. The office’s share of positive obligations moved from 0.45% to 0%, a change of −0.5 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 1 award.

Contract types, competition, and procurement methods

From Oct 14, 2025 through Oct 13, 2026, 542 awards had positive obligations totaling $1.7B. Np was the leading reported procedure, accounting for 50.5% of positive obligations. Awards with a reported parent IDV accounted for 68.2%. Reported awards used contract vehicles such as SEER, CTSU, and WHI Regional Centers.

Leading award type
68.2%
Delivery Order
Leading reported procedure
50.5%
Np
Reported parent IDV
68.2%
of positive obligations had a reported parent IDV
Median reported offers
2
295 of 542 awards reported offers

Observed contract vehicles

Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.

  • SEER

    $43.1M

    2.6% of positive obligations · 20 matched awards

  • CTSU

    $24.2M

    1.5% of positive obligations · 4 matched awards

  • WHI Regional Centers

    $13.7M

    0.82% of positive obligations · 4 matched awards

Buying method changes

Compared with Oct 14, 2024–Oct 13, 2025. Based on 542 current awards and 545 preceding awards with positive net obligations.

Reported full-and-open obligation share
26.7%
Down from 82.0% in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 541715 peer median, parent-IDV obligation share is 11.6 percentage points higher, reported full-and-open obligation share is 20.2 percentage points higher, delivery-order obligation share is 11.6 percentage points higher, and median positive award obligations are 264.1% higher.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share68.2%56.6%+11.6 pts
Reported full-and-open obligation share26.7%6.5%+20.2 pts
Delivery-order obligation share68.2%56.6%+11.6 pts
Median positive award obligations$901K$247K+264.1%
Peer cohort and comparison limits

The peer median gives each of the 9 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)350$1.1B68.2%
Definitive Contract(D)140$522.0M31.4%
Purchase Order(B)52$6.1M0.37%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)348$1.1B68.1%
FSS(C)2$815K0.050%
Not reported192$528.1M31.8%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)247$1.0B61.1%
Multiple Award(M)103$118.3M7.1%
Not reported192$528.1M31.8%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Np(NEGOTIATED PROPOSAL/QUOTE)139$838.9M50.5%
Negotiated Proposal/Quote(NP)161$417.3M25.1%
Sss(ONLY ONE SOURCE)51$164.0M9.9%
Only One Source(SSS)32$77.3M4.7%
Mafo(SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY)55$66.6M4.0%
Subject to Multiple Award Fair Opportunity(MAFO)48$51.7M3.1%
Other reported values56$44.1M2.7%

Extent competed

Reported valueAwardsPositive obligationsShare
A(FULL AND OPEN COMPETITION)178$882.9M53.2%
Full and Open Competition(A)195$443.7M26.7%
C(NOT COMPETED)48$157.4M9.5%
Not Competed(C)29$67.6M4.1%
D(FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES)20$46.0M2.8%
Full and Open Competition After Exclusion of Sources(D)18$37.4M2.3%
Other reported values54$25.1M1.5%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Fair Opportunity Given(FAIR)81$109.1M6.6%
Competitive Set Aside(CSA)3$3.3M0.20%
Follow-on Action Following Competitive Initial Action(FOO)12$3.3M0.20%
Only One Source - Other(ONE)5$2.4M0.15%
Other Statutory Authority(OSA)2$178K0.010%
Not reported439$1.5B92.9%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Mobilization, Essential R&d (FAR 6.302-3)(MES)45$167.9M10.1%
Only One Source-Other (FAR 6.302-1 Other)(ONE)30$51.5M3.1%
Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH)10$19.2M1.2%
Urgency (FAR 6.302-2)(URG)1$3.5M0.21%
SAP Non-Competition (FAR 13)(SP2)17$2.6M0.16%
Unsolicited Research Proposal (FAR 6.302-1(A)(2)(I))(UR)1$2.1M0.13%
Not reported438$1.4B85.1%

Contract pricing types

Reported valueAwardsPositive obligationsShare
U(COST PLUS FIXED FEE)110$824.8M49.7%
Cost Plus Fixed Fee(U)112$349.0M21.0%
Cost No Fee(S)88$150.3M9.1%
S(COST NO FEE)56$149.0M9.0%
J(FIRM FIXED PRICE)93$77.9M4.7%
T(COST SHARING)14$39.9M2.4%
Other reported values69$69.1M4.2%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
Health R&d Services; Health Care Services; Applied Research(AN12)235$1.1B63.3%
Health R&d Services; Health Care Services; Basic Research(AN11)108$256.0M15.4%
Health R&d Services; Health Care Services; Experimental Development(AN13)21$109.0M6.6%
Support- Professional: Other(R499)35$56.2M3.4%
General Science and Technology R&d Services; General Science and Technology; Applied Research(AJ12)12$41.6M2.5%
General Science and Technology R&d Services; General Science and Technology; Basic Research(AJ11)20$27.2M1.6%
Other reported values111$119.3M7.2%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
National Institutes of Health(7529)392$1.3B80.8%
Centers for Medicare and Medicaid Services(7530)19$123.2M7.4%
Office of Assistant Secretary for Preparedness and Response(7505)13$73.9M4.5%
Food and Drug Administration(7524)43$35.1M2.1%
Centers for Disease Control and Prevention(7523)32$33.8M2.0%
Departmental Offices(1406)12$26.9M1.6%
Other reported values31$26.4M1.6%

Awarding offices

Reported valueAwardsPositive obligationsShare
Nih Nci(75N910)93$739.2M44.5%
National Institutes of Health Niaid(75N930)86$255.2M15.4%
Ofc of Acquisition and Grants Mgmt(75FCMC)19$123.2M7.4%
National Institutes of Health Nida(75N950)40$92.3M5.6%
National Institutes of Health Nhlbi(75N920)55$80.5M4.8%
Barda - Aspr / Daappo / Barda Dcma(75A501)13$73.9M4.5%
Other reported values236$295.8M17.8%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
75N91019D00024(7529)53$633.5M38.2%
75FCMC23D0004(7530)41$163.7M9.9%
75N91022D00009(7529)2$22.2M1.3%
75N94025D00003(7529)4$18.7M1.1%
75N93020D00011(7529)2$11.5M0.69%
75N92021D00001(7529)1$10.2M0.62%
75N92023D00011(7529)2$10.2M0.62%
75N92025D00012(7529)2$9.5M0.57%
Other reported values243$252.4M15.2%
Not reported192$528.1M31.8%

Exact vehicle-match evidence

Reported award data linked 31 awards to a specific catalog vehicle.

Offers, award size, and timing

Median reported offers
2 median
295 reported · 247 not reported
Positive award obligations
$901K median
$259K–$2.6M middle 50%
Reported performance period
775 days (~2.1 years) median
542 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 13, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
39 of 228prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
29.9%of positive obligations in the last 12 months
Leading four prime contractors
50.4%of positive obligations in the last 12 months
Leading eight prime contractors
57.9%of positive obligations in the last 12 months

Based on $1.5B in positive obligations during the 12 months ending Oct 13, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 14, 2024–Oct 13, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $434.1M

    29.9%

    Dollar movement

    −$138.0M

    vs. prior 12 months

    Last 12mo awards

    104 awards

    154 actions

    Historical and award details for LEIDOS BIOMEDICAL RESEARCH INC
    Obligations: prior → latest
    $572.1M → $434.1M
    −24.1%
    Share: prior → latest
    39.2% → 29.9%
    −9.3 percentage points
    All-period obligations
    $3.9B
    38.5% of all-period positive obligations · 181 awards
    Recorded activity
    Since Oct 27, 2021
    through Sep 29, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported104115
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $163.3M

    11.3%

    Dollar movement

    +$39.6M

    vs. prior 12 months

    Last 12mo awards

    49 awards

    82 actions

    Historical and award details for THE MITRE CORPORATION
    Obligations: prior → latest
    $123.7M → $163.3M
    +32.0%
    Share: prior → latest
    8.5% → 11.3%
    +2.8 percentage points
    All-period obligations
    $385.4M
    3.8% of all-period positive obligations · 74 awards
    Recorded activity
    Since Sep 27, 2023
    through Sep 29, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported4950
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $86.7M

    6.0%

    Dollar movement

    +$15.7M

    vs. prior 12 months

    Last 12mo awards

    19 awards

    33 actions

    Historical and award details for WESTAT, INC.
    Obligations: prior → latest
    $70.9M → $86.7M
    +22.2%
    Share: prior → latest
    4.9% → 6.0%
    +1.1 percentage points
    All-period obligations
    $284.3M
    2.8% of all-period positive obligations · 49 awards
    Recorded activity
    Since Oct 14, 2021
    through Sep 29, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside12
    Not reported1821
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $46.8M

    3.2%

    Dollar movement

    +$774K

    vs. prior 12 months

    Last 12mo awards

    10 awards

    14 actions

    Historical and award details for TECHNICAL RESOURCES INTERNATIONAL, INC.
    Obligations: prior → latest
    $46.1M → $46.8M
    +1.7%
    Share: prior → latest
    3.1% → 3.2%
    +0.1 percentage points
    All-period obligations
    $187.2M
    1.8% of all-period positive obligations · 18 awards
    Recorded activity
    Since Oct 28, 2021
    through Aug 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside22
    Reported no set-aside33
    Not reported57
    Reported small business1012
    All-period set-aside types
    • 3 · Total small business
  5. #5

    Last 12mo obligations

    $42.0M

    2.9%

    Dollar movement

    +$15.5M

    vs. prior 12 months

    Last 12mo awards

    25 awards

    40 actions

    Historical and award details for DUKE UNIVERSITY
    Obligations: prior → latest
    $26.5M → $42.0M
    +58.6%
    Share: prior → latest
    1.8% → 2.9%
    +1.1 percentage points
    All-period obligations
    $209.7M
    2.0% of all-period positive obligations · 51 awards
    Recorded activity
    Since Oct 12, 2021
    through Sep 29, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside911
    Not reported1617
    Reported small business00
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $24.4M

    1.7%

    Dollar movement

    +$1.3M

    vs. prior 12 months

    Last 12mo awards

    10 awards

    16 actions

    Historical and award details for AMERICAN TYPE CULTURE COLLECTION
    Obligations: prior → latest
    $23.1M → $24.4M
    +5.5%
    Share: prior → latest
    1.6% → 1.7%
    +0.1 percentage points
    All-period obligations
    $167.6M
    1.6% of all-period positive obligations · 21 awards
    Recorded activity
    Since Oct 14, 2021
    through Oct 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside22
    Not reported88
    Reported small business00
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $24.3M

    1.7%

    Dollar movement

    +$5.8M

    vs. prior 12 months

    Last 12mo awards

    1 award

    7 actions

    Historical and award details for BATTELLE MEMORIAL INSTITUTE
    Obligations: prior → latest
    $18.5M → $24.3M
    +31.2%
    Share: prior → latest
    1.3% → 1.7%
    +0.4 percentage points
    All-period obligations
    $56.7M
    0.55% of all-period positive obligations · 2 awards
    Recorded activity
    Since Mar 16, 2022
    through Sep 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $18.5M

    1.3%

    Dollar movement

    +$18.5M

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for SCYNEXIS INC
    Obligations: prior → latest
    $0 → $18.5M
    Not comparable
    Share: prior → latest
    0% → 1.3%
    +1.3 percentage points
    All-period obligations
    $18.5M
    0.18% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 25, 2026
    through Sep 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $17.6M

    1.2%

    Dollar movement

    −$329K

    vs. prior 12 months

    Last 12mo awards

    26 awards

    33 actions

    Historical and award details for THE EMMES COMPANY, LLC
    Obligations: prior → latest
    $17.9M → $17.6M
    −1.8%
    Share: prior → latest
    1.2% → 1.2%
    0.0 percentage points
    All-period obligations
    $136.9M
    1.3% of all-period positive obligations · 74 awards
    Recorded activity
    Since Oct 28, 2021
    through Sep 24, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside22
    Not reported2421
    Reported small business11
    All-period set-aside types
    • 1 · Total small business
  10. #10

    Last 12mo obligations

    $17.0M

    1.2%

    Dollar movement

    −$2.6M

    vs. prior 12 months

    Last 12mo awards

    26 awards

    35 actions

    Historical and award details for SRI INTERNATIONAL
    Obligations: prior → latest
    $19.6M → $17.0M
    −13.4%
    Share: prior → latest
    1.3% → 1.2%
    −0.2 percentage points
    All-period obligations
    $102.9M
    1.0% of all-period positive obligations · 68 awards
    Recorded activity
    Since Oct 12, 2021
    through Sep 29, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside13
    Not reported2525
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $16.5M

    1.1%

    Dollar movement

    +$16.5M

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Obligations: prior → latest
    $0 → $16.5M
    Not comparable
    Share: prior → latest
    0% → 1.1%
    +1.1 percentage points
    All-period obligations
    $38.0M
    0.37% of all-period positive obligations · 4 awards
    Recorded activity
    Since May 24, 2022
    through Aug 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $15.1M

    1.0%

    Dollar movement

    +$1.5M

    vs. prior 12 months

    Last 12mo awards

    4 awards

    6 actions

    Historical and award details for FRED HUTCHINSON CANCER CENTER
    Obligations: prior → latest
    $13.6M → $15.1M
    +11.1%
    Share: prior → latest
    0.93% → 1.0%
    +0.1 percentage points
    All-period obligations
    $58.5M
    0.57% of all-period positive obligations · 10 awards
    Recorded activity
    Since Jul 12, 2022
    through Aug 31, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported44
    Reported small business00
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $15.0M

    1.0%

    Dollar movement

    +$15.0M

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for FLOSONICS MEDICAL LLC
    Obligations: prior → latest
    $0 → $15.0M
    Not comparable
    Share: prior → latest
    0% → 1.0%
    +1.0 percentage points
    All-period obligations
    $15.0M
    0.15% of all-period positive obligations · 1 award
    Recorded activity
    Since Jun 5, 2026
    through Jun 5, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $14.5M

    1.0%

    Dollar movement

    −$10.8M

    vs. prior 12 months

    Last 12mo awards

    5 awards

    17 actions

    Historical and award details for ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Obligations: prior → latest
    $25.3M → $14.5M
    −42.8%
    Share: prior → latest
    1.7% → 1.0%
    −0.7 percentage points
    All-period obligations
    $150.4M
    1.5% of all-period positive obligations · 5 awards
    Recorded activity
    Since Oct 12, 2021
    through Sep 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside54
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $14.2M

    0.98%

    Dollar movement

    +$13.6M

    vs. prior 12 months

    Last 12mo awards

    2 awards

    8 actions

    Historical and award details for REVAGENIX INC
    Obligations: prior → latest
    $671K → $14.2M
    +2021.5%
    Share: prior → latest
    0.050% → 0.98%
    +0.9 percentage points
    All-period obligations
    $49.4M
    0.48% of all-period positive obligations · 2 awards
    Recorded activity
    Since Oct 14, 2021
    through Jul 10, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside22
    Not reported00
    Reported small business22
    All-period set-aside types

    None reported.

Potential federal contract recompetes

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

SAFESOURCE DIRECT LLC

EO 14398; INDUSTRIAL BASE EXPANSION OF NITRILE GLOVES MANUFACTURING

The reported potential end date is Dec 15, 2026. Current award value is 100.0% of reported potential value ($144.8M of $144.8M).

Performance period

94.6%

As of Oct 13, 2026Potential end Dec 15, 2026

Current award value as a share of potential value

100.0%

$144.8M current$144.8M potential
Supporting data

Reported performance starts Sep 30, 2023.

No later potential end date is reported; current and potential end dates are both Dec 15, 2026.

$144.8M is obligated against $144.8M in current reported award value (100.0%).

Reported potential end dates: Sep 29, 2025 → Jun 30, 2026 → Dec 15, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50223C00024

LEIDOS BIOMEDICAL RESEARCH INC

EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)

The reported potential end date is Oct 31, 2026. Current award value is 100.0% of reported potential value ($79.9M of $79.9M).

Performance period

99.1%

As of Oct 13, 2026Potential end Oct 31, 2026

Current award value as a share of potential value

100.0%

$79.9M current$79.9M potential
Supporting data

Reported performance starts Feb 10, 2021.

No later potential end date is reported; current and potential end dates are both Oct 31, 2026.

$79.9M is obligated against $79.9M in current reported award value (100.0%).

Reported potential end dates: Feb 10, 2026 → Oct 31, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75N91021F00001

QYK BRANDS LLC

INDUSTRIAL BASE EXPANSION (IBX) FOR METHACRYLIC ACID FOR KEY CHEMICALS.

The reported potential end date is Dec 15, 2026. Current award value is 100.0% of reported potential value ($48.3M of $48.3M).

Performance period

94.2%

As of Oct 13, 2026Potential end Dec 15, 2026

Current award value as a share of potential value

100.0%

$48.3M current$48.3M potential
Supporting data

Reported performance starts Dec 18, 2023.

No later potential end date is reported; current and potential end dates are both Dec 15, 2026.

$48.3M is obligated against $48.3M in current reported award value (100.0%).

Reported potential end dates: Aug 17, 2026 → Dec 15, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50424C00001

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

EO 14398 - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS)

The reported potential end date moved later 3 times in the latest 12 months.

Performance period

90.6%

As of Oct 13, 2026Potential end Jul 9, 2027

Current award value as a share of potential value

73.8%

$110.9M current$150.2M potential
Supporting data

Reported performance starts Sep 10, 2019.

No later potential end date is reported; current and potential end dates are both Jul 9, 2027.

$110.9M is obligated against $110.9M in current reported award value (100.0%).

Reported potential end dates: Aug 4, 2025 → Sep 14, 2025 → Feb 6, 2026 → Aug 14, 2026 → Sep 24, 2026 → Feb 28, 2027 → Jun 1, 2027 → Jul 9, 2027.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75N93019C00051

PHILIPS NORTH AMERICA LLC

THE PURPOSE OF THIS MODIFICATION IS TO: 1. CLIN 0001: DECREASE THE TOTAL AMOUNT FUNDED FROM $34,892,573.62 BY $459.74 TO $34,893,033.36. 2. THE TOTAL CONTRACT VALUE IS HEREBY DECREASED FROM $68,167,100.36 BY $459.74 TO $68,166,640.62.

The reported potential end date is Dec 31, 2026. Current award value is 100.0% of reported potential value ($68.2M of $68.2M).

Performance period

96.7%

As of Oct 13, 2026Potential end Dec 31, 2026

Current award value as a share of potential value

100.0%

$68.2M current$68.2M potential
Supporting data

Reported performance starts May 8, 2020.

No later potential end date is reported; current and potential end dates are both Dec 31, 2026.

$68.2M is obligated against $68.2M in current reported award value (100.0%).

Reported potential end dates: May 31, 2025 → May 31, 2024 → May 31, 2025 → Dec 31, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50120C00097

THE EMMES COMPANY, LLC

DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH (NEIS VI)

The reported potential end date is Oct 31, 2026. Current award value is 100.0% of reported potential value ($30.1M of $30.1M).

Performance period

99.0%

As of Oct 13, 2026Potential end Oct 31, 2026

Current award value as a share of potential value

100.0%

$30.1M current$30.1M potential
Supporting data

Reported performance starts Nov 1, 2021.

No later potential end date is reported; current and potential end dates are both Oct 31, 2026.

$30.1M is obligated against $30.1M in current reported award value (100.0%).

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75N98022C00001

These are research leads, not confirmed recompetes. USAspending records through Oct 13, 2026; reported dates and values can change through later modifications.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Deobligation

This action

−$74.5M

LEIDOS BIOMEDICAL RESEARCH INC

NATIONAL INSTITUTES OF HEALTH NIAID

NIAID COVID-19 ACTIV3

Why it stands out

This award recorded a material contraction.

The action removed $74.5M. A deobligation does not by itself show lower requirement demand.

Award net obligations
$159.1M
Share of 12-month positive obligations
5.1%
Supporting data
Prime contractor
#1 · 29.9% share
−9.3 percentage points · $138.0M net decline; action accounted for 53.9%
Funding office
#2 · 21.6% attributed share
−0.6 percentage points · $11.8M net decline; action exceeded it by $62.7M
Related:Largest share lossUnusually large action
PIID 75N91020F00039 · Mod P00011
Modification

This action

+$102.8M

LEIDOS BIOMEDICAL RESEARCH INC

NATIONAL INSTITUTES OF HEALTH NCATS

ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)

Why it stands out

The award grew alongside stronger office-attributed spending.

The modification added $102.8M while office-attributed obligations rose $113.1M overall.

Award net obligations
$141.7M
Share of 12-month positive obligations
7.1%
Supporting data
Prime contractor
#1 · 29.9% share
$138.0M net decline despite this positive action
Funding office
#4 · 7.9% attributed share
up 27 ranks · +7.9 percentage points · $113.1M net increase; action accounted for 90.9%
Related:Funding office gain
PIID 75N91021F00004 · Mod P00009
Modification

This action

+$113.7M

LEIDOS BIOMEDICAL RESEARCH INC

NIH NCI

NCI OPERATIONAL TASK ORDER, FY26-FY27

Why it stands out

This award grew while spending attributed to its office declined.

The modification added $113.7M while office-attributed obligations fell $260.9M overall.

Award net obligations
$483.8M
Share of 12-month positive obligations
7.8%
Supporting data
Prime contractor
#1 · 29.9% share
$138.0M net decline despite this positive action
Funding office
#1 · 26.7% attributed share
$260.9M net decline despite this positive action
Related:Unusually large action
PIID 75N91025F00016 · Mod P00011
Modification

This action

+$47.8M

WESTAT, INC.

NATIONAL INSTITUTES OF HEALTH NIDA

POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY PERIOD OF PERFORMANCE: 02/01/2024 - 11/30/2030.

Why it stands out

The award grew alongside stronger contractor activity.

The modification added $47.8M while contractor obligations rose $15.7M overall.

Award net obligations
$85.5M
Share of 12-month positive obligations
3.3%
Supporting data
Prime contractor
#3 · 6.0% share
+1.1 percentage points · $15.7M net increase; action exceeded it by $32.1M
PIID 75N95024C00003 · Mod P00009
Base award

This action

+$18.5M

SCYNEXIS INC

BARDA - ASPR / DAAPPO / BARDA DCMA

ADVANCE THE DEVELOPMENT OF SCY-247, A NOVEL ANTIFUNGAL CURRENTLY IN PHASE 1 CLINICAL TRIALS, FOR THE TREATMENT OF INVASIVE CANDIDIASIS AND PROPHYLAXIS OF INVASIVE FUNGAL DISEASE AS ORAL AND IC FORMULA

Why it stands out

No activity for this contractor was reported in this market during the preceding 12 months.

The base action placed the contractor #8 in this market by positive obligations over the latest 12 months.

Award net obligations
$18.5M
Share of 12-month positive obligations
1.3%
Supporting data
Prime contractor
#8 · 1.3% share
Newly active in this market; no actions were reported in the preceding 12 months
Funding office
#7 · 4.9% attributed share
up 3 ranks · +3.6 percentage points · $51.2M net increase; action accounted for 36.1%
PIID 75A50126C00007

BARDA - ASPR / DAAPPO / BARDA DCMA

ADD ADDITIONAL FUNDING TO THE BASE PERIOD; UPDATE COA THRESHOLD TO $350,000; ADD BERYL VOIGT AS ALTERNATE COR; UPDATE FAR/HHSAR CLAUSES PER EXECUTIVE ORDERS AND REVOLUTIONARY FAR/HHSAR OVERHAUL (RFO); UPDATE SOW AND CONTRACT MILESTONES AND DELIVERABL

Why it stands out

No activity for this contractor was reported in this market during the preceding 12 months.

The modification placed the contractor #11 in this market by positive obligations over the latest 12 months.

Award net obligations
$37.6M
Share of 12-month positive obligations
1.1%
Supporting data
Prime contractor
#11 · 1.1% share
Newly active in this market; no actions were reported in the preceding 12 months
PIID 75A50123C00047 · Mod P00002
View recent award activity by date (10)
  1. GNOMX CORP.Deobligation · PIID 75A50124C00038
    Action−$24K
    Award net obligations$725K
  2. LEIDOS BIOMEDICAL RESEARCH INCBase award · PIID 75N91026F00034
    Action+$72.2M
    Award net obligations$72.2M
  3. THE MITRE CORPORATIONBase award · PIID 75FCMC26F0164
    Action+$4.7M
    Award net obligations$4.7M
  4. THE MITRE CORPORATIONBase award · PIID 75FCMC26F0167
    Action+$1.4M
    Award net obligations$1.4M
  5. WESTAT, INC.Deobligation · PIID 75N94021F00001
    Action−$1.3M
    Award net obligations$1.1M
  6. SRI INTERNATIONALBase award · PIID 75N94026F00003
    Action+$597K
    Award net obligations$597K
  7. THE GOVERNORS OF THE UNIVERSITY OF CALGARYBase award · PIID 75F40126C00212
    Action+$346K
    Award net obligations$346K
  8. THE MITRE CORPORATIONModification · PIID 75F40126F80199
    Action+$250K
    Award net obligations$3.2M
  9. HENNEPIN HEALTHCARE RESEARCH INSTITUTEDeobligation · PIID 75N94019C00006
    Action−$147K
    Award net obligations$9.6M
  10. WESTAT, INC.Deobligation · PIID 75N94019F00106
    Action−$102K
    Award net obligations$2.8M

HHS NAICS 541715 market FAQs

Answers based on reported federal contract data.

Who are the top HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) contractors?

In the 12 months through October 13, 2026, LEIDOS BIOMEDICAL RESEARCH INC, THE MITRE CORPORATION, and WESTAT, INC. were the leading HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) prime contractors by positive obligations.

  1. #1

    LEIDOS BIOMEDICAL RESEARCH INC

    $434,066,793 in positive obligations

  2. #2

    THE MITRE CORPORATION

    $163,348,149 in positive obligations

  3. #3

    WESTAT, INC.

    $86,652,381 in positive obligations

Rankings use reported USAspending award data.

Did HHS contract obligations decrease under NAICS 541715?

Yes. Measured by net prime contract obligations, reported HHS activity in the research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) market decreased 0.9% from $1,447,437,059 in the preceding 12 months to $1,434,242,992 in the 12 months through October 13, 2026.

Latest 12 months
$1,434,242,992
Net prime contract obligations
Preceding 12 months
$1,447,437,059
Net prime contract obligations
Change
−0.9%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent HHS contract award activity was reported under NAICS 541715?

Recent HHS contract award activity reported in the research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) market included actions for LEIDOS BIOMEDICAL RESEARCH INC, WESTAT, INC., and SCYNEXIS INC during the 12 months through October 13, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for HHS contracts under NAICS 541715?

From October 14, 2025 through October 13, 2026, HHS reported 542 positive-obligation awards for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) under NAICS 541715. The leading award type was delivery order. The leading reported procedure was np.

Positive-obligation awards
542
Leading reported procedure
Np
50.5% of positive obligations
Leading award type
Delivery Order
68.2% of positive obligations
Full and open
26.7%
of positive obligations
Reported parent IDV
68.2%
of positive obligations
Observed vehicles
SEER, CTSU, and WHI Regional Centers
Exact matches from reported parent PIIDs

Percentages use positive obligations as the denominator.

Which HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) awards may warrant recompete research?

6 HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) awards may warrant recompete research based on reported potential-end dates, including awards held by SAFESOURCE DIRECT LLC, LEIDOS BIOMEDICAL RESEARCH INC, and QYK BRANDS LLC.

Research leads, not confirmed recompetes. Dates may change through later modifications.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through October 13, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.

Review data methodology